• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Unapproved compounded drugs linked to equine deaths

August 1, 2019

Medications formulated by Rapid Equine Solutions have been tied to three deaths, FDA says.

The FDA is warning veterinarians and horse owners that one lot of compounded combination drug product containing pyrimethamine and toltrazuril has been associated with adverse events in at least three horses, two in Maine and one in Ohio, according to a release.

Testing completed by the agency found that this lot of the product contained approximately 18 to 21 times the pyrimethamine indicated on the label. High doses of this medication can cause clinical signs such as seizures, fever and death, the release notes.

Rapid Equine Solutions of Aston, Pennsylvania, compounded the product, which was labeled as containing toltrazuril 416 mg/ml and pyrimethamine 17 mg/ml, and packaged in 60 ml oral paste syringes for the treatment of the neurologic disease Equine Protozoal Myeloencephalitis (EPM).

Advertisement

The products from the lot have been accounted for and are no longer in distribution. The company learned of the adverse events in late May and initiated a recall to consumers the same day. The FDA is working with company and state agencies to investigate the adverse events, the release states.

According to the release, an incident linked to a different compounder also involved erroneously formulated compounded pyrimethamine/toltrazuril products that led to four equine deaths in 2014. It notes that compounded products are not FDA-approved animal drugs and that toltrazuril is not approved for use in horses.

There are several drugs that are FDA-approved for the treatment of EPM, according to the FDA, and the agency encourages horse owners to consult their veterinarian for treatment advice. The agency asks veterinarians, horse owners and caretakers to report adverse events in horses being treated with compounded pyrimethamine-containing products. That can be done here.

Related Content:

RecallsEquine MedicineBreaking NewsEquine
CBD provides one mustang with a second chance
CBD provides one mustang with a second chance
Updated EquiTrace app integrates wth HISA Portal
Updated EquiTrace app integrates wth HISA Portal
Kaytee Products Inc. announces voluntarily recall
Kaytee Products Inc. announces voluntarily recall

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement